Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

News

Working with cancer: the film Monday pleads for benevolence

World Cancer Day, February 4, is an opportunity to remember that 50% of people with cancer are afraid to talk to their employer about it. To break down prejudice and stop the stigmatization of the disease in the workplace, the Publicis Foundation is launching a global campaign entitled "Working with cancer". Gustave Roussy and the Cancer At Work association are proud to be the partners of this operation for France.

Published on

Working with cancer

World Cancer Day, February 4, is an opportunity to remember that 50% of people with cancer are afraid to talk to their employer about it. To break down prejudice and stop the stigmatization of the disease in the workplace, the Publicis Foundation is launching a global campaign entitled "Working with cancer". Gustave Roussy and the Cancer At Work association are proud to be the partners of this operation for France.

Working with cancer

Fear of rejection, social and professional taboo... cancer is still "an unspeakable disease" in companies for half of the employees concerned. This is the observation made by Arthur Sadoun, Chairman of the Board of Publicis Groupe, who was confronted with the disease in April 2022. The executive, who has chosen to make his cancer public, has received thousands of testimonials, notably from Publicis employees. A Publicis Health study conducted in October 2022 shows that, for 92% of employees, the support received at work can have a positive impact on their health. The company has a key role to play in helping and encouraging employees living with cancer to return to work.  

Cette vidéo est hébergée par Youtube. Pour la lire sur notre site, il est nécessaire d'autoriser les cookies.
Accepter les cookies

 

Mobilizing to talk about cancer in companies

To break the taboo of cancer in the workplace, the Publicis Foundation has launched the "Working with cancer" campaign in partnership with Gustave Roussy and the Cancer at Work association. This large-scale communication campaign, launched at the World Economic Forum in Davos on January 17, is designed to encourage companies, large and small, to commit to creating conditions that are favorable to the return to work of employees suffering from cancer. All are invited to join the movement on the platform workingwithcancerpledge.com

From January 31 to April, this campaign takes a new turn to address patients, their colleagues and loved ones, and their employers around the world, with the film Monday broadcast on TV channels and social networks. This touching film depicts the return to work of a woman and a man who are welcomed by their colleagues. The journey of the disease is suggested in images revealing their story and their difficulties.

Preparing for the "after-cancer" period at Gustave Roussy 

As a partner, Gustave Roussy is supporting this campaign alongside the Cancer At Work association, Memorial Sloan Kettering Cancer Center in the United States and MacMillan Cancer Support in the UK. The issue of staying active and/or returning to work has always been a major concern for Gustave Roussy, which has dedicated one of its medical-scientific projects, Interval, to the post-cancer period. This research theme is integrated into several research projects, in particular the CANTO cohort, which aims to improve the quality of life of women with localized breast cancer.

The Interdisciplinary Department for the Organization of Patient Pathways (DIOPP),  headed by Dr. Florian Scotté, was created in 2020 to streamline the provision of care and pathways, but also to go further in patient care, taking also into account the post-cancer period. This pioneering department manages supportive care, and the psychological and social aspects of the disease, in an ongoing effort to innovate for the benefit of patients and their families.

 

Last news

  • Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction

    On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.

    Photographie - chirurgiens en salle d'opération
  • Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide

    The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.

    Badge Word's best specialized hospitals
  • Living with and beyond cancer: the promises and challenges of digital health

    In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings. 

     Emmanuel Mussault, Ines Vaz-Luis, Maria Alice Franzoi
  • Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care

    The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.

    Flyer évènement - Personalized cancer prevention